2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease affecting 30% of the world ’s population and is often associated with metabolic disorders such as metabolic synd...

Source: Diabetology and Metabolic Syndrome - January 19, 2024 Category: Endocrinology Authors: Am élio F. Godoy-Matos, Cynthia Melissa Valério, Wellington S. Silva Júnior, João Marcello de Araujo-Neto and Marcello Casaccia Bertoluci Tags: Review Source Type: research